• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样肽受体表型的结构基础。

A structural basis for amylin receptor phenotype.

机构信息

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

ARC Centre for Cryo-Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

出版信息

Science. 2022 Mar 25;375(6587):eabm9609. doi: 10.1126/science.abm9609.

DOI:10.1126/science.abm9609
PMID:35324283
Abstract

Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMYR, AMYR, and AMYR. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMYR with salmon CT (sCT), AMYR with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.

摘要

胰岛淀粉样多肽受体(AMYRs)是降钙素(CT)受体(CTR)和三种受体活性修饰蛋白(RAMPs)之一的异二聚体,分别为 AMYR、AMYR 和 AMYR。选择性 AMYR 激动剂和双 AMYR/CTR 激动剂正在被开发为肥胖症治疗药物;然而,肽结合和选择性的分子基础尚不清楚。我们确定了与胰岛淀粉样多肽结合的活性 AMYRs、与鲑鱼 CT(sCT)结合的 AMYR、与 sCT 或人 CT(hCT)结合的 AMYR 以及与胰岛淀粉样多肽、sCT 或 hCT 结合的 CTR 的结构和动力学。结合 RAMP 和我们称之为旁路基序的有序中肽基序,所有 AMYRs 结合的胰岛淀粉样多肽复合物的构象都相似。结合 CT 的 AMYR 复合物是独特的,与结合 CT 的 CTR 复合物重叠。我们的研究结果表明,基于 CT 的肽激活 AMYRs 的方式与基于胰岛淀粉样多肽的肽激活 AMYRs 的方式不同。这对 AMYR 治疗药物的开发具有重要意义。

相似文献

1
A structural basis for amylin receptor phenotype.淀粉样肽受体表型的结构基础。
Science. 2022 Mar 25;375(6587):eabm9609. doi: 10.1126/science.abm9609.
2
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists.开发一种用于直接评估选择性胰岛淀粉样多肽受体激活的新方法,揭示了选择性和非选择性肽激动剂在行为上的新差异。
Mol Pharmacol. 2024 Apr 17;105(5):359-373. doi: 10.1124/molpharm.123.000865.
3
AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists.AM833 是降钙素家族 G 蛋白偶联受体的新型激动剂:与六种选择性和非选择性激动剂的药理学比较。
J Pharmacol Exp Ther. 2021 Jun;377(3):417-440. doi: 10.1124/jpet.121.000567. Epub 2021 Mar 16.
4
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.降钙素与胰淀素受体肽相互作用机制:深入了解受体活性修饰蛋白对降钙素受体的肽结合模式及变构调节
J Biol Chem. 2016 Apr 15;291(16):8686-700. doi: 10.1074/jbc.M115.713628. Epub 2016 Feb 19.
5
Structural insight into selectivity of amylin and calcitonin receptor agonists.淀粉样多肽和降钙素受体激动剂选择性的结构见解。
Nat Chem Biol. 2024 Feb;20(2):162-169. doi: 10.1038/s41589-023-01393-4. Epub 2023 Aug 3.
6
Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.人胰淀素 1 受体与 CGRP 和 Gs 蛋白复合物的冷冻电镜结构。
Biochemistry. 2024 May 7;63(9):1089-1096. doi: 10.1021/acs.biochem.4c00114. Epub 2024 Apr 11.
7
Palatable food access impacts expression of amylin receptor components in the mesocorticolimbic system.可口食物的获取会影响中边缘系统中胰岛淀粉样肽受体成分的表达。
Exp Physiol. 2020 Jun;105(6):1012-1024. doi: 10.1113/EP088356. Epub 2020 May 13.
8
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.多种胰淀素受体源于受体活性修饰蛋白与降钙素受体基因产物的相互作用。
Mol Pharmacol. 1999 Jul;56(1):235-42. doi: 10.1124/mol.56.1.235.
9
Effects of sub-chronic amylin receptor activation on alcohol-induced locomotor stimulation and monoamine levels in mice.亚慢性淀粉样蛋白受体激活对小鼠酒精诱导的运动刺激和单胺水平的影响。
Psychopharmacology (Berl). 2020 Nov;237(11):3249-3257. doi: 10.1007/s00213-020-05607-8. Epub 2020 Jul 10.
10
A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice.在雄性小鼠中,与鲑鱼降钙素相比,受体活性修饰蛋白在胰淀素选择性受体激动剂 NN1213 的亚慢性作用中具有选择性作用,可影响体重和食物摄入。
Eur J Neurosci. 2021 Aug;54(3):4863-4876. doi: 10.1111/ejn.15376. Epub 2021 Jul 9.

引用本文的文献

1
Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors.对卡格列净肽在胰淀素和降钙素受体中双重激活的结构和机制见解。
Acta Pharmacol Sin. 2025 Aug 22. doi: 10.1038/s41401-025-01635-2.
2
Receptor Activity-Modifying Protein 3 enhances GLP-1-mediated Insulin Secretion.受体活性修饰蛋白3增强胰高血糖素样肽-1介导的胰岛素分泌。
bioRxiv. 2025 Aug 13:2025.01.24.634724. doi: 10.1101/2025.01.24.634724.
3
Amylin receptor subunit interactions are modulated by agonists and determine signaling.胰淀素受体亚基相互作用受激动剂调节并决定信号传导。
Sci Signal. 2025 Aug 19;18(900):eadt8127. doi: 10.1126/scisignal.adt8127.
4
Amylin Receptor 1 Mutagenesis Revealed a Potential Role of Calcitonin Serine 29 in Receptor Interaction.胰淀素受体1诱变揭示了降钙素丝氨酸29在受体相互作用中的潜在作用。
Biomedicines. 2025 Jul 21;13(7):1787. doi: 10.3390/biomedicines13071787.
5
The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.胰淀素(一种单分子胰高血糖素样肽-1和胰淀素受体激动剂)对小鼠和大鼠体重及代谢功能障碍的影响。
EBioMedicine. 2025 Jul 23;118:105862. doi: 10.1016/j.ebiom.2025.105862.
6
Insights into the structural dynamics of the secretin family (class B1) G protein-coupled receptors.促胰液素家族(B1类)G蛋白偶联受体的结构动力学研究进展。
J Biol Chem. 2025 Jul 9;301(8):110466. doi: 10.1016/j.jbc.2025.110466.
7
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.卡格列净通过脑降钙素基因相关肽受体1和3降低体重。
EBioMedicine. 2025 Jul 2;118:105836. doi: 10.1016/j.ebiom.2025.105836.
8
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.胰淀素:从作用机制到在糖尿病和肥胖症中的未来临床潜力
Diabetes Ther. 2025 Jun;16(6):1207-1227. doi: 10.1007/s13300-025-01733-8. Epub 2025 May 7.
9
GLP-1-based therapies for diabetes, obesity and beyond.基于胰高血糖素样肽-1(GLP-1)的糖尿病、肥胖症及其他疾病治疗方法。
Nat Rev Drug Discov. 2025 Apr 25. doi: 10.1038/s41573-025-01183-8.
10
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.卡格列净肽与降钙素及胰淀素受体结合的结构和动力学特征。
Nat Commun. 2025 Apr 10;16(1):3389. doi: 10.1038/s41467-025-58680-y.